FDA: Papaya-linked Salmonella outbreak now over
The U.S. Food and Drug Administration (FDA) says that the Salmonella outbreak linked to papayas first reported in June now appears to be over.
The case relates to papayas imported from Mexico and sold by New York-based Agroson's under the Cavi brand.
In total, there were 81 illnesses across nine states and 27 hospitalizations.
"According to the CDC, this outbreak appears to be over; however, the FDA’s investigational activities associated with this outbreak are ongoing," the FDA said.
"The epidemiological and traceback information collected in the investigation confirmed that Agroson’s LLC of Bronx, New York, was the exclusive distributor of the imported papayas that made consumers from this outbreak sick."
On August 26, the FDA issued a statement calling on the papaya industry to improve practices and better protect consumers. Additionally, the FDA issued a warning letter to Agroson’s LLC.
Despite the FDA in July asking the company to conduct a voluntary recall of the products, it did not do so.
The FDA said that consumers and distributors no longer need to avoid or withhold Cavi brand whole, fresh papayas imported from Mexico.